➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
McKesson
Colorcon
Johnson and Johnson

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Mirodenafil

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Mirodenafil?

Mirodenafil is an investigational drug.

There have been 4 clinical trials for Mirodenafil. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Renal Insufficiency, Kidney Diseases, and Erectile Dysfunction. The leading clinical trial sponsors are SK Chemicals Co.,Ltd., Asan Medical Center, and Janssen Korea, Ltd., Korea.

There are thirteen US patents protecting this investigational drug and one hundred and sixty-seven international patents.

Recent Clinical Trials for Mirodenafil
TitleSponsorPhase
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mgSK Chemicals Co.,Ltd.Phase 1
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mgSK Chemicals Co.,Ltd.Phase 1
A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile DysfunctionJanssen Korea, Ltd., KoreaPhase 4

See all Mirodenafil clinical trials

Clinical Trial Summary for Mirodenafil

Top disease conditions for Mirodenafil
Top clinical trial sponsors for Mirodenafil

See all Mirodenafil clinical trials

US Patents for Mirodenafil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Mirodenafil   Start Trial Treatment of erectile dysfunction and other indications Strategic Science & Technologies, LLC (Cambridge, MA)   Start Trial
Mirodenafil   Start Trial Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods Indiana University Research and Technology Corporation (Indianapolis, IN) United States Government as Represented by the Department of Veterans Affairs (Washington, DC)   Start Trial
Mirodenafil   Start Trial Pyrrolopyrimidinone derivatives, process of preparation and use SK Chemicals Co., Ltd. (Suwon, KR) In2Gen Co., Ltd. (Seoul, KR)   Start Trial
Mirodenafil   Start Trial Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (Seongnam, Gyeonggi-Do, KR)   Start Trial
Mirodenafil   Start Trial Methods and compositions for oral administration of melanocortin receptor agonist compounds   Start Trial
Mirodenafil   Start Trial Treatment of erectile dysfunction and other indications Strategic Science & Technologies, LLC (Cambridge, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Mirodenafil

Drugname Country Document Number Estimated Expiration Related US Patent
Mirodenafil Australia AU2009348470 2029-06-24   Start Trial
Mirodenafil Australia AU2015203547 2029-06-24   Start Trial
Mirodenafil Australia AU2016200596 2029-06-24   Start Trial
Mirodenafil Australia AU2017206223 2029-06-24   Start Trial
Mirodenafil Australia AU2019200847 2029-06-24   Start Trial
Mirodenafil Brazil BRPI0925099 2029-06-24   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
McKesson
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.